Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Accumulated Depreciation (2019 - 2025)

Historic Accumulated Depreciation for Beam Therapeutics (BEAM) over the last 7 years, with Q3 2025 value amounting to $88.6 million.

  • Beam Therapeutics' Accumulated Depreciation rose 3290.68% to $88.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.6 million, marking a year-over-year increase of 3290.68%. This contributed to the annual value of $72.1 million for FY2024, which is 4369.1% up from last year.
  • Beam Therapeutics' Accumulated Depreciation amounted to $88.6 million in Q3 2025, which was up 3290.68% from $83.2 million recorded in Q2 2025.
  • Beam Therapeutics' Accumulated Depreciation's 5-year high stood at $88.6 million during Q3 2025, with a 5-year trough of $10.3 million in Q1 2021.
  • Over the past 5 years, Beam Therapeutics' median Accumulated Depreciation value was $39.6 million (recorded in 2023), while the average stood at $43.4 million.
  • Its Accumulated Depreciation has fluctuated over the past 5 years, first surged by 9477.58% in 2021, then surged by 3290.68% in 2025.
  • Quarter analysis of 5 years shows Beam Therapeutics' Accumulated Depreciation stood at $16.1 million in 2021, then surged by 87.61% to $30.2 million in 2022, then soared by 66.33% to $50.2 million in 2023, then surged by 43.69% to $72.1 million in 2024, then increased by 22.87% to $88.6 million in 2025.
  • Its Accumulated Depreciation was $88.6 million in Q3 2025, compared to $83.2 million in Q2 2025 and $77.6 million in Q1 2025.